AIkido Pharma rises on $42.02 mln buyout offer from Shalom Auerbach
** Shares of AIkido Pharma Inc AIKI.O up 3.8% premarket at
$6.49
** Co confirms receipt of an unsolicited offer from Shalom
Auerbach to acquire all of co's outstanding common stock for
$8/share in cash
** Offer represents a premium of 28% over the last closing
price of AIKI at $6.25
** Up to Tuesday's close, stock was down ~37% YTD
(Reporting by Raghav Mahobe)
((Raghav.Mahobe@thomsonreuters.com;))
Recent news on Dominari Holdings
See all newsBelgium's Aikido launches cybersecurity AI model as demand for local tools grows
Brief: New America Acquisition I Corp. Announces Chief Financial Officer Transition
Trump sons-backed Aureus leaps after Powerus starts counter-drone manufacturing in Gulf
Dominari Holdings Q2 revenue falls on fewer deal closings
Dominari Holdings Q1 revenue jumps 395%